Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer
JNCI Cancer Spectrum · 2026
DOI: 10.1093/jncics/pkag078 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Lauren Raymond-King und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, Yale School of Medicine, New Haven, CT, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatectomy, Carcinoma, Pancreatic Ductal, Frailty. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Aging and the National Institute of Health, NIA NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Curative-intent treatment for pancreatic ductal adenocarcinoma necessitates major surgery and chemotherapy, yet many patients do not undergo resection. Frailty may contribute to this phenomenon, but its prevalence and association with pancreatectomy in pancreatic ductal adenocarcinoma remains poorly defined. This study describes the distribution of frailty and its association with curative-intent surgery in a nationally representative cohort of patients with nonmetastatic pancreatic ductal adenocarcinoma.
Methods
Using Surveillance, Epidemiology, and End Results–Medicare data (2013-2019), we identified patients aged 66 years and older with nonmetastatic pancreatic ductal adenocarcinoma. Frailty was categorized as nonfrail, prefrail, mildly frail, or moderately to severely frail using the claims-based frailty index over the 12 months preceding diagnosis. We evaluated frailty distributions via kernel density estimation. We assessed the association between frailty category and receipt of surgery via logistic regression.
Results
Among 8237 patients (mean age = 78 years, 57.6% female, 77.4% White race), 2486 (30.2%) underwent curative-intent pancreatectomy. Surgery was performed in 39.7% of nonfrail and 30.7% of prefrail patients; after adjustment, prefrail patients had similar odds of resection compared to nonfrail patients (adjusted odds ratio [OR] = 1.01, 95% confidence interval [CI] = 0.89 to 1.16). In contrast, 15.8% of mildly frail and 5.7% of moderately to severely frail patients underwent surgery; both groups had statistically significant lower odds of surgery vs nonfrail patients (mildly frail adjusted OR = 0.53, 95% CI = 0.43 to 0.66; moderately to severely frail adjusted OR = 0.18, 95% CI = 0.11 to 0.30).
Conclusions
Remarkably, less than 40% of nonfrail patients with nonmetastatic pancreatic ductal adenocarcinoma underwent surgery, suggesting that curative-intent treatment remains infrequent even among lower-risk adults. Frailty is also common and strongly associated with decreased odds of surgical resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Oncology, Yale School of Medicine, New Haven, CT, United States.
- National Clinician Scholars Program (NCSP), Yale University, New Haven, CT, United States.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT, United States.
- Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, CT, United States.
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
ORCID-Profile: Bhramar Mukherjee, John W Kunstman
Förderung
- NCI NIH HHS
- National Institute of Aging and the National Institute of Health
- NIA NIH HHS
Zitieren
APA
Raymond-King, L., McGrath, S., Mukherjee, B., Wang, Y., Parikh, H., Rothen, J., Soulos, P. R., Gross, C. P., & Kunstman, J. W. (2026). Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag078
Vancouver
Raymond-King L, McGrath S, Mukherjee B, Wang Y, Parikh H, Rothen J, et al. Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag078
BibTeX
@article{RaymondKing2026,
author = {Raymond-King, Lauren and McGrath, Sean and Mukherjee, Bhramar and Wang, Yiran and Parikh, Harsh and Rothen, John and Soulos, Pamela R and Gross, Cary P and Kunstman, John W},
title = {Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer},
journal = {JNCI Cancer Spectrum},
year = {2026},
doi = {10.1093/jncics/pkag078}
}
EUVIMED